Insurance is the sub-sector of Financials whose companies sell promises to pay future, uncertain claims in exchange for premiums collected today. That single feature — revenue arrives before the cost of goods is known — makes insurers unlike almost any other equity: they are simultaneously an underwriting business (pricing and selecting risk) and an investment business (deploying the policyholder money they hold in the interim, called float). The core tension of the whole sector is that these two engines can move in opposite directions — a company can lose money writing policies yet earn a strong return overall on its investments, or write profitably and earn float essentially for free. Analyzing an insurer therefore means refusing to read any single headline number — reported profit, "earnings up," even a combined ratio — without first decomposing which engine produced it and how durable that source is.

What this section covers

This is the Financials → Insurance playbook: the mental models and metrics used to understand insurer equities as investments and to compare them to one another. It is fundamental / sector-analysis knowledge, not a technical-analysis or entry-timing topic — there is no chart-pattern angle to insurance as a sector, and none should be forced. The section assumes the reader is trying to judge an insurer's business quality, earnings durability, and relative value, then map those onto the macro drivers (rates, the underwriting cycle, catastrophes) that move insurance stocks.

It defers the granular depth to three child nodes (below) and does not duplicate them.

The core tension and why it matters

Three facts drive everything in insurance analysis:

1. Claims are estimated, not known. Reported earnings depend on management's reserve estimates for claims not yet fully paid. Those estimates can be wrong for years before reversing — so an insurer can look profitable while quietly under-reserving, and look unprofitable while a competitor over-reserved. Reserve development (favorable vs. adverse) is a permanent caveat over every other metric. 2. Two profit engines, two skills. Underwriting profit comes from pricing discipline; investment profit comes from asset-liability management and the prevailing yield curve. The single most common analytical error in the sector is crediting management skill for what is really a tailwind — a benign catastrophe year, a soft reserve release, or a higher interest-rate environment lifting investment income. 3. The business is not one industry. P&C, life, and reinsurance have different float durations, dominant risks, and valuation lenses. Applying one template across them produces nonsense (see the taxonomy child).

When it matters vs. when it doesn't

The insurance lens matters whenever an insurer ticker enters a screen, a relative-value call, or a business-quality assessment — and especially in rate-regime shifts and catastrophe seasons, which hit the two subtypes differently. Per FactSet, life insurers' stocks correlate strongly with the 10-year Treasury (because they earn a spread on long-duration assets), while a 25 bp move in the 10-year is sometimes associated with outsized swings in life names; P&C carriers, whose float is shorter, care far more about underwriting margin than the bond yield. As a sector, insurance generally trades as a lower-growth, value-oriented, often lower-beta group relative to the broad market (Allstate, for example, recurs on low-beta S&P 500 lists), so it is rarely the locus of momentum or high-velocity setups. The lens matters least for short-horizon technical trades, where insurer-specific fundamentals are noise relative to price action.

How insurers are valued (orientation, not depth)

Because earnings are estimate-laden and lumpy, the sector leans on balance-sheet valuation more than income multiples:

• Price-to-book (P/B) is the primary multiple for P&C and most insurers; book value is the cleaner anchor when reported earnings are reserve-sensitive.
• Embedded value / price-to-EV is the standard lens for life insurers, capturing the present value of profits locked into in-force long-duration policies.
• Return on equity ties it together, but must be read against the two-engine decomposition — a high ROE driven by investment leverage in a high-rate year is not the same quality as one driven by sub-100 underwriting.

These valuation choices are widely taught (Investing.com, Eqvista, mergers-and-inquisitions FIG modeling) and are not seriously contested; the debate is always over inputs (reserve adequacy, assumption realism), never the framework.

Map of the sub-topics

This section breaks into three child nodes; consult them for depth:

• Underwriting & Combined Ratio (001-underwriting-and-combined-ratio) — the workhorse metric for P&C underwriting quality (combined ratio = loss ratio + expense ratio; below 100 = underwriting profit). Covers the formula, the trade-vs-statutory basis trap, accident-year vs. calendar-year, and the #1 misuse: treating it as net profitability.
• Float & Investment Income (002-float-and-investment-income) — the second engine. How float is computed off the balance sheet, the "cost of float" / negative-cost-float framework (Buffett), net investment income vs. capital gains, investment leverage (commonly cited as roughly low-single-digit multiples for P&C vs. ~8–14x for life insurers per FactSet, reflecting life's longer-duration spread business — exact figures and citations live in that child), and why rising float is not automatically a sign of quality.
• P&C vs. Life vs. Reinsurance (003-p-and-c-vs-life-vs-reinsurance) — the taxonomy: how the three subtypes differ in float duration, dominant risk, earnings driver, rate sensitivity, and valuation lens, plus the underwriting cycle (hard/soft markets) and the warning that large insurers are composites best read at the segment level.

Sources

• Investing.com — How to Evaluate Insurance Stocks Like a Pro (P/B, combined ratio, book value as primary anchors): https://www.investing.com/academy/analysis/how-to-evaluate-insurance-stocks/
• Eqvista — Insurance Company Valuation (P/B, embedded value, discounted-net-income method): https://eqvista.com/company-valuation/insurance-company-valuation/
• Mergers & Inquisitions — Bank & Insurance Financial Modeling 101 (book-value-driven valuation for financials): https://mergersandinquisitions.com/bank-insurance-modeling-101/
• FactSet — Understanding the Interest Rate Sensitivity of Insurance Companies (life vs. P&C rate sensitivity; 10-year Treasury correlation): https://insight.factset.com/understanding-the-interest-rate-sensitivity-of-insurance-companies
• Sure Dividend — Low Beta S&P 500 Stocks (insurers such as Allstate as low-beta names): https://www.suredividend.com/low-beta-stocks/
• Sibling child nodes (this section): Underwriting & Combined Ratio; Float & Investment Income; P&C vs. Life vs. Reinsurance — which carry the sourced detail and base rates summarized here.

Confidence: medium. This is a section-overview synthesizing three already-sourced child docs plus a landscape check on valuation framework (P/B, embedded value) and rate sensitivity. Subtype-specific figures and base rates live in the children with their own citations; the rate-sensitivity and low-beta characterizations are directional/qualitative, not precise constants.